Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
23947
CAS Number:
205260-07-7
6,7-Diméthoxy-2-Méthyl-4-(Pipérazine-1-Yl)Quinazoline
Documents
$282.62 /100 mg
Taille
Request Bulk Quote
Product Information

6,7-Dimethoxy-2-Methyl-4-(Piperazin-1-Yl)Quinazoline is a versatile compound with significant potential in pharmaceutical research and development. This compound, characterized by its unique piperazine moiety, has been explored for its efficacy in various therapeutic applications, particularly in the field of oncology and neurology. Its structural features allow it to interact effectively with biological targets, making it a valuable candidate for drug formulation aimed at treating complex diseases. Researchers have noted its promising activity in modulating specific pathways, which could lead to innovative treatments for conditions such as cancer and neurological disorders.

In addition to its therapeutic potential, 6,7-Dimethoxy-2-Methyl-4-(Piperazin-1-Yl)Quinazoline demonstrates favorable properties that enhance its usability in laboratory settings. Its solubility profile and stability under various conditions make it an ideal choice for both in vitro and in vivo studies. This compound stands out among similar quinazoline derivatives due to its enhanced bioactivity and selectivity, providing researchers with a powerful tool for advancing their studies. Whether you are developing new pharmaceuticals or conducting cutting-edge research, this compound offers a promising avenue for exploration and innovation.

CAS Number
205260-07-7
Molecular Formula
C15H20N4O2
Molecular Weight
288.35
MDL Number
MFCD09998230
PubChem ID
11392079
Conditions
Conserver à 0-8°C
General Information
CAS Number
205260-07-7
Molecular Formula
C15H20N4O2
Molecular Weight
288.35
MDL Number
MFCD09998230
PubChem ID
11392079
Conditions
Conserver à 0-8°C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Non
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

6,7-Dimethoxy-2-Methyl-4-(Piperazin-1-Yl)Quinazoline is widely utilized in research focused on:

  • Pharmaceutical Development: This compound is explored for its potential as a therapeutic agent in treating various diseases, including cancer and neurological disorders, due to its ability to interact with specific biological targets.
  • Antidepressant Research: It is studied for its effects on serotonin receptors, making it a candidate for developing new antidepressant medications that may offer fewer side effects compared to traditional treatments.
  • Neuropharmacology: The compound's piperazine group is significant in neuropharmacology, where it is investigated for its role in modulating neurotransmitter systems, potentially leading to advancements in treating anxiety and mood disorders.
  • Drug Design: Researchers utilize this compound in structure-activity relationship studies to design more effective drugs, leveraging its unique chemical structure to optimize efficacy and reduce toxicity.
  • Biochemical Assays: It serves as a valuable tool in biochemical assays to study enzyme interactions and receptor binding, providing insights that can guide further drug development and therapeutic strategies.

Citations